Philip Chaikin

1.7k total citations
32 papers, 1.3k citations indexed

About

Philip Chaikin is a scholar working on Oncology, Cardiology and Cardiovascular Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Philip Chaikin has authored 32 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Cardiology and Cardiovascular Medicine and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Philip Chaikin's work include Parkinson's Disease Mechanisms and Treatments (4 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Statistical Methods in Clinical Trials (4 papers). Philip Chaikin is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (4 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Statistical Methods in Clinical Trials (4 papers). Philip Chaikin collaborates with scholars based in United States, Japan and Canada. Philip Chaikin's co-authors include Akihisa Mori, Gerald Rhodes, Mark Stacy, Mark Guttman, Lauri Welles, James W. Tetrud, Gerald Batist, Paul Tuite, Peter A. LeWitt and Christine E. Swenson and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Annals of Neurology.

In The Last Decade

Philip Chaikin

32 papers receiving 1.2k citations

Peers

Philip Chaikin

NEURO

PHYSI

CMN

ONCOL

Ljubica Vučićević Serbia

Andrea Lapucci Italy

Daqing Sun China

Maja Misirkić Serbia

Mario de la Mata Spain

Qianqian Liu China

Liming Tan China

Xuefei Zhang China

Yue Du China

Eva-Anne Subileau Austria

Ljubica Vučićević Serbia

Philip Chaikin

41 ×0.1

NEURO

81 ×0.3

PHYSI

642 ×2.3

45 ×0.2

CMN

193 ×1.3

ONCOL

Citations per year, relative to Philip Chaikin Philip Chaikin (= 1×) peers Ljubica Vučićević

Countries citing papers authored by Philip Chaikin

Since Specialization

Citations

This map shows the geographic impact of Philip Chaikin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Chaikin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Chaikin more than expected).

Fields of papers citing papers by Philip Chaikin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Chaikin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Chaikin. The network helps show where Philip Chaikin may publish in the future.

Co-authorship network of co-authors of Philip Chaikin

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Chaikin. A scholar is included among the top collaborators of Philip Chaikin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Chaikin. Philip Chaikin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Donnenberg, Vera S., Philip Chaikin, Maja Mandić, et al.. (2019). Core Entrustable Professional Activities in Clinical Pharmacology for Entering Residency: Common Problem Drugs and How to Prescribe Them. The Journal of Clinical Pharmacology. 59(7). 915–922. 1 indexed citations

Knebel, William, et al.. (2011). Population Pharmacokinetic‐Pharmacodynamic Analysis of Istradefylline in Patients With Parkinson Disease. The Journal of Clinical Pharmacology. 52(10). 1468–1481. 10 indexed citations

Pourcher, Emmanuelle, Hubert H. Fernandez, Mark Stacy, et al.. (2011). Istradefylline for Parkinson's disease patients experiencing motor fluctuations: Results of the KW-6002-US-018 study. Parkinsonism & Related Disorders. 18(2). 178–184. 91 indexed citations

Knebel, William, et al.. (2010). Population Pharmacokinetic Analysis of Istradefylline in Healthy Subjects and in Patients With Parkinson's Disease. The Journal of Clinical Pharmacology. 51(1). 40–52. 17 indexed citations

Dvorchik, Barry, et al.. (2008). A Study of the Pharmacokinetic Interaction of Istradefylline, a Novel Therapeutic for Parkinson's Disease, and Atorvastatin. The Journal of Clinical Pharmacology. 48(9). 1092–1098. 20 indexed citations

LeWitt, Peter A., Mark Guttman, James W. Tetrud, et al.. (2008). Adenosine A _2A receptor antagonist istradefylline (KW‐6002) reduces “off” time in Parkinson's disease: A double‐blind, randomized, multicenter clinical trial (6002‐US‐005). Annals of Neurology. 63(3). 295–302. 281 indexed citations

Chaikin, Philip, et al.. (2007). 2.225 Evaluation of the pharmacokinetic interaction of istradefylline and ketoconazole. Parkinsonism & Related Disorders. 13. S104–S104. 5 indexed citations

Durrleman, Sylvain & Philip Chaikin. (2003). The use of putative placebo in active control trials: two applications in a regulatory setting. Statistics in Medicine. 22(6). 941–952. 28 indexed citations

Bruno, René, Robert Olivares, J. Bérille, et al.. (2003). Alpha-1-acid glycoprotein as an independent predictor for treatment effects and a prognostic factor of survival in patients with non-small cell lung cancer treated with docetaxel.. PubMed. 9(3). 1077–82. 68 indexed citations

10.

Swenson, Christine E., Lois E. Bolcsak, Gerald Batist, et al.. (2003). Pharmacokinetics of doxorubicin administered i.v. as Myocet (TLC D-99; liposome-encapsulated doxorubicin citrate) compared with conventional doxorubicin when given in combination with cyclophosphamide in patients with metastatic breast cancer. Anti-Cancer Drugs. 14(3). 239–246. 83 indexed citations

11.

Batist, Gerald, Jeremy Barton, Philip Chaikin, Christine E. Swenson, & Lauri Welles. (2002). Myocet (liposome-encapsulated doxorubicin citrate): a new approach in breast cancer therapy. Expert Opinion on Pharmacotherapy. 3(12). 1739–1751. 133 indexed citations

12.

Rhodes, Gerald, Shashank Rohatagi, Michael Gillen, et al.. (2001). In Vitro and In Vivo Techniques Used in Drug Development for Evaluation of Dose Delivery of Inhaled Corticosteroids. The Journal of Clinical Pharmacology. 41(1). 7–18. 3 indexed citations

13.

Gillen, Michael, et al.. (2001). Effects of supratherapeutic doses of ebastine and terfenadine on the QT interval. British Journal of Clinical Pharmacology. 52(2). 201–204. 27 indexed citations

14.

Rohatagi, Shashank, Gerald Rhodes, & Philip Chaikin. (1999). Absolute Oral Versus Inhaled Bioavailability: Significance for Inhaled Drugs with Special Reference to Inhaled Glucocorticoids. The Journal of Clinical Pharmacology. 39(7). 661–663. 17 indexed citations

15.

Moss, Arthur J., Philip Chaikin, Joaquín de Nova García, et al.. (1999). A review of the cardiac systemic side‐effects of antihistamines: ebastine. Clinical & Experimental Allergy. 29(S3). 200–205. 27 indexed citations

16.

Cutler, Neal R., John J. Sramek, David J. Greenblatt, et al.. (1997). Defining the Maximum Tolerated Dose: Investigator, Academic, Industry and Regulatory Perspectives. The Journal of Clinical Pharmacology. 37(9). 767–783. 20 indexed citations

17.

Barbhaiya, Rashmi H., Umesh Shukla, Philip Chaikin, Douglas S. Greene, & P. Marathe. (1996). Nefazodone pharmacokinetics: assessment of nonlinearity, intra-subject variability and time to attain steady-state plasma concentrations after dose escalation and de-escalation. European Journal of Clinical Pharmacology. 50(1-2). 101–107. 16 indexed citations

18.

Salazar, Daniel E., et al.. (1995). Pharmacokinetic and Pharmacodynamic Evaluation of Warfarin and Nefazodone Coadministration in Healthy Subjects. The Journal of Clinical Pharmacology. 35(7). 730–738. 24 indexed citations

19.

Chaikin, Philip, Thomas B. Marriott, David Simon, & Howard Weintraub. (1988). Comparative Bioavailability of Suprofen After Coadministration with Food or Milk. The Journal of Clinical Pharmacology. 28(12). 1132–1135. 3 indexed citations

20.

Chaikin, Philip & Joseph Adir. (1987). Unusual Absorption Profile of Phenytoin in a Massive Overdose Case. The Journal of Clinical Pharmacology. 27(1). 70–73. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact